Early knee OA appears to be a stable condition, with a low proportion of knees showing worsening structural damage or symptom progression over time.

Patients with chronic pain treated with the novel FAST SCS systems may achieve significant and durable pain relief for up to 12 months of follow-up.

GEA is effective and safe for reducing OA symptoms among patients with knee OA that is refractory to conservative therapy.

Faced with rising cases of bird flu virus being detected in raw milk in California, the USDA announced it would mandate testing for the virus in milk nationwide.

Patients, especially women, with PTSD in low-income areas were more likely to rapidly reduce or discontinue opioids than those in high-income areas.

Neuropathic pain is common in spondyloarthritis, particularly among women and those with comorbid obesity or fibromyalgia.

The FDA has granted Orphan Drug designation to BRC-002 (cannabidiol botanical extract) for the treatment of complex regional pain syndrome.

Among patients with poststroke pain, scrambler therapy may lead to a reduction in pain, but its long-term effect is unclear.

Many general practitioners prescribe antibiotics for suspected CAP even when chest radiograph results are negative.

TAP block provided no clinically meaningful difference vs placebo in pain relief following minimally invasive abdominal surgery.

Continuous adductor canal block resulted in better outcomes and less need for opioids than epidural analgesia after inpatient total knee arthroplasty.

Naldemedine may be an effective concomitant treatment in patients with cancer who are insufficiently responsive to magnesium oxide therapy for OIC.